SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (4849)10/23/2001 8:26:15 PM
From: Miljenko Zuanic  Respond to of 52153
 
Thanks Wilder.

I think that Ronald Garren is very balanced and objective reporter, with good idea.

Personally, I abounded *vaccines* as cancer play because of the unclear path they are taking. Who will most benefit from vaccines and when? To answer this trails need to be long and large, times and money consumption. Hope Biomira will have right answer in one year.

Miljenko



To: keokalani'nui who wrote (4849)10/23/2001 8:57:29 PM
From: thebeach  Respond to of 52153
 
Hi everyone,thought you might like to see the latest news on Procyon as well as a chart outlining its performance,any feedback will be appreciated both good and bad.Thanks.
stockhouse.com
stockcharts.com[l,a]daclnimy[p][vc60][iUe12,26,9!Lc20]


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News